Sankaranarayanan K, von Duyn A, Loos M J, Meschini R, Natarajan A T
MGC Department of Radiation Genetics & Chemical Mutagenesis, Sylvius Laboratories, State University of Leiden, The Netherlands.
Genet Res. 1990 Oct-Dec;56(2-3):267-76. doi: 10.1017/s0016672300035370.
Peripheral blood lymphocytes from normal human volunteers or from Down syndrome patients were pre-treated with sodium butyrate (a compound which is known to induce structural modifications in the chromatin through hyperacetylation of nucleosomal core histones) and exposed to X-irradiation or treated with bleomycin in vitro in the G0 and/or G1 stage(s) of the cell cycle. The frequencies of chromosomal aberrations in the first mitosis after treatment were scored. The results show an enhancement in the yield of aberrations in the butyrate pre-treated groups. However, the absolute frequencies of chromosomal aberrations as well as the relative increases with butyrate pre-treatment varied between blood samples from different donors suggesting the existence of inter-individual variations. There is a parallelism between the effects of X-irradiation or of combined treatments in G0 and G1 stages and between effects observed in the X-ray and bleomycin series. The increase in the yields of chromosomal aberrations in butyrate-treated and X-irradiated lymphocytes (relative to those which received X-irradiation alone) is interpreted as a consequence of the inhibition of repair of DNA damage by butyrate.
来自正常人类志愿者或唐氏综合征患者的外周血淋巴细胞,先用丁酸钠(一种已知可通过核小体核心组蛋白的超乙酰化诱导染色质结构修饰的化合物)进行预处理,然后在细胞周期的G0和/或G1期接受X射线照射或体外博来霉素处理。对处理后第一次有丝分裂中染色体畸变的频率进行评分。结果显示,丁酸钠预处理组的畸变产率有所提高。然而,不同供体血样中染色体畸变的绝对频率以及丁酸钠预处理后的相对增加有所不同,这表明存在个体间差异。在G0和G1期X射线照射或联合处理的效果之间,以及在X射线和博来霉素系列中观察到的效果之间存在平行关系。丁酸钠处理并经X射线照射的淋巴细胞中染色体畸变产率的增加(相对于仅接受X射线照射的淋巴细胞)被解释为丁酸钠抑制DNA损伤修复的结果。